NYSE:ZTSPharmaceuticals
Assessing Zoetis (ZTS) Valuation After Steep Share Price Weakness And Profitability Concerns
Zoetis stock: recent performance and context
Zoetis (ZTS) has drawn attention after a steep share price decline, with the stock down about 31% over the past month and about 38% over the past 3 months, which has shifted investor focus toward fundamentals.
See our latest analysis for Zoetis.
At a share price of US$80.23, Zoetis has seen its short term momentum weaken, with a 30 day share price return down 31%, and a 1 year total shareholder return down 51%, pointing to fading sentiment despite...